Search results
These 6 Simple COPD Self-Care Tips Help You Breathe Easier, Experts Say
Woman's World via Yahoo News· 1 week ago"COPD isn't a curable disease, but it's definitely manageable," assures Sucharita...in Boston, MA....
How To Stop Coughing
Health.com· 7 hours agoIt is also a common symptom of many acute (short-term) and chronic (long-term) conditions, such as the common cold, flu, allergies, asthma,...
Inflammation Affects Furan Exposure and COPD Association
Medscape· 6 days agoAdults with COPD showed higher blood levels of the environmental pollutant furan than those without ...
Trelegy Ellipta: Side effects and what to do about them
Medical News Today· 2 weeks agoTrelegy Ellipta (fluticasone/umeclidinium/vilanterol) is a brand-name medication that’s prescribed ...
Lucius Partners, LLC Portfolio Company AerWave Medical, Inc. Initiates Patient Screening in...
Clearfield Progress· 1 day agoLucius Partners, LLC ("LP") today announced that its portfolio company, AerWave Medical, Inc., has begun screening patients for inclusion in First in Human (FIH) studies of ...
AMGEN TO PRESENT TEZSPIRE® PHASE 2A COPD DATA AT ATS 2024
Tehachapi News· 1 week agoPDT. This study did not exclude any patients based on their baseline eosinophil count (BEC) and intentionally enrolled patients with a broad range of BECs.
Vitamin D, multinutrients may boost lung health for COPD sufferers
Nutraingredients.com· 1 week agoChinese researchers conducted a meta-analysis that showed supplementation with vitamin D by itself...
BTIG starts Theravance Biopharma stock on BUY, cites 'pivotal' data for ampreloxetine By...
Investing.com· 2 weeks agoThe coverage initiation is based on the anticipation of pivotal data for the company's drug...
ASLAN Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides...
Investing.com· 2 weeks agoASLAN Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides...
Yupelri dosage: Form, strength, how to take, and more
Medical News Today· 1 week agoYupelri (revefenacin) is a brand-name drug that’s prescribed for chronic obstructive pulmonary disease (COPD) in adults. Yupelri comes as a solution that ...
